U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524972) titled 'Antenatal Magnesium Sulphate in High-Risk Preterm Patients' on April 02.
Brief Summary: The goal of this clinical trial is to evaluate whether antenatal magnesium sulphate reduces the risk of cerebral palsy in infants born to women at high risk of preterm birth. It will also assess the safety of magnesium sulfate for both the mother and the neonate. The main question it aims to answer is whether magnesium sulphate given before anticipated preterm delivery decreases the incidence of cerebral palsy without causing significant maternal or neonatal adverse effects. Researchers will compare magnesium sulphate with a placebo in women at ...